Contents
[hide]
[show]

The TRIP13 gene is one of the genes associated with variegated conditions. It has been studied extensively and its related information can be found in various scientific resources, such as PubMed, OMIM, and other databases. The gene plays a crucial role in chromatid separation during cell division, and changes or mutations in this gene can lead to aneuploidy and other genetic conditions.

Patients with mutations in the TRIP13 gene may exhibit a range of symptoms, depending on the specific variant and other genetic factors. This can result in a condition sometimes called TRIP13-related mosaic aneuploidy syndrome. The symptoms and characteristics of this syndrome can vary widely among affected individuals.

Genetic testing for mutations in the TRIP13 gene can be used to diagnose the syndrome and provide additional information about the patient’s condition. Various tests are available, including chromosome analysis and DNA sequencing, to identify changes or variants in this gene. The results of these tests can be compared to a catalog of known mutations and variants, such as those listed in the registry of genetic diseases.

Scientific articles and references in databases like PubMed provide valuable information on the TRIP13 gene, its functions, and its role in different diseases and conditions. These resources can help researchers and healthcare professionals better understand the gene and its implications for human health.

Genetic changes in the TRIP13 gene have been linked to various health conditions. These genetic changes can occur in different forms, known as variants, which can lead to different symptoms and outcomes.

Some health conditions caused by TRIP13 gene variants include:

The average length of the portion of a doctor appointment in which the patient actually sees the doctor is up from previous years, rising by about 12 seconds per year, according to Reuters. However, 60% of physicians report dissatisfaction with the amount of time they spend with their patients, athenaInsight Many doctors now spend more time on paperwork than seeing patients, and a primary care physician who spends 5 minutes of face-to-face time with a patient will spend another 19.3 minutes, on average, working on that patient’s electronic health records (EHRs).

  • Variegated aneuploidy related syndrome: This is a rare genetic disorder characterized by abnormal numbers or structures of chromosomes in cells, called aneuploidy. Symptoms of this syndrome can vary widely, but may include intellectual disability, developmental delay, and facial abnormalities.
  • Mosaic variegated aneuploidy: This condition is similar to variegated aneuploidy related syndrome and is characterized by mosaic aneuploidy in various tissues of the body. Individuals with this condition may also experience growth retardation, intellectual disability, and an increased risk of cancer.

To learn more about these health conditions and the specific symptoms associated with them, you can refer to scientific articles and resources such as PubMed and OMIM. These databases provide valuable information on genetic diseases and their related symptoms. Additionally, genetic testing can be used to diagnose these conditions and provide further information on the specific genetic changes involved.

In order to access the latest research and information on TRIP13 gene variants and associated health conditions, you can search for relevant articles in PubMed using keywords such as “TRIP13 gene” or the specific condition names. These articles often provide detailed information on the genetic changes, symptoms, and potential treatments for these conditions.

The Genetic Testing Registry is another useful resource for finding information on available genetic tests for TRIP13 gene variants and related conditions. This registry provides information on the availability, accuracy, and clinical validity of various genetic tests.

In conclusion, genetic changes in the TRIP13 gene can lead to various health conditions such as variegated aneuploidy related syndrome and mosaic variegated aneuploidy. Understanding these genetic changes and their associated symptoms is central to diagnosis and treatment of these conditions. Utilizing scientific databases and genetic testing resources can provide valuable information for both healthcare professionals and individuals seeking to understand these conditions.

Mosaic variegated aneuploidy syndrome

Mosaic variegated aneuploidy syndrome (MVA) is a genetic disorder caused by changes in the TRIP13 gene. This syndrome is also called mosaic variegated aneuploidy with central chromatid separation (MVA CCS).

See also  CDC6 gene

MVA is characterized by an abnormal number and distribution of chromosomes in cells. Individuals with MVA may have an increased risk of developing various health problems, including intellectual disability, developmental delay, and cancer.

The TRIP13 gene, also known as the homolog of the yeast gene pch2, plays a critical role in the separation of genetic material during cell division. Changes in this gene can disrupt the normal process of chromosome separation, leading to the mosaic variegated aneuploidy syndrome.

To diagnose MVA, genetic tests can be performed to identify changes in the TRIP13 gene. These tests may include sequencing the gene or analyzing specific regions for genetic variants.

Additional information about MVA can be found in scientific articles on pubmed and OMIM databases. These resources provide references to related articles, genetic testing information, and other health-related information.

Individuals with suspected MVA may also consider contacting genetic counseling services or registries for further information and support. These organizations can provide information about testing options, available resources, and connections to other individuals affected by MVA.

It is important to note that MVA is a rare condition and may be misdiagnosed or underdiagnosed. Therefore, individuals who suspect they have MVA or have a family history of the condition should consult with a healthcare professional for proper evaluation and diagnosis.

Other Names for This Gene

TRIP13 gene is also known by other names including:

  • Tumor susceptibility gene 101 protein homolog
  • Mosaic variegated aneuploidy syndrome protein
  • Anaphase-promoting complex subunit 7
  • Tumor susceptibility gene 13 protein

These alternative names for the TRIP13 gene are used in various databases, scientific articles, and resources to refer to the gene and its related functions.

  1. The TRIP13 gene has been studied in various databases, and its association with different diseases and conditions has been documented.
  2. Genetic tests and screening for mutations in the TRIP13 gene have been developed to identify potential health risks and diagnose related disorders.
  3. Publications referenced in PubMed and other scientific databases contain additional information on the TRIP13 gene and its role in cellular processes.
  4. The TRIP13 gene is also listed in the Online Mendelian Inheritance in Man (OMIM) database, which catalogs genetic diseases and related genes.
  5. Research has shown that mutations or changes in the TRIP13 gene can lead to a condition called mosaic variegated aneuploidy syndrome (MVA), characterized by chromosomal abnormalities and an increased risk of cancer.

In summary, the TRIP13 gene, also known by other names, has been extensively studied and its role in various diseases and cellular processes is well-documented in scientific literature, databases, and resources.

Additional Information Resources

Here are some additional resources for more information on the TRIP13 gene:

  • OMIM: The Online Mendelian Inheritance in Man (OMIM) database provides information on genes and genetic conditions. You can find more details about the TRIP13 gene on the OMIM website.
  • Gene Databases: There are several databases that contain information on genes and their related functions. Some popular gene databases include GenBank, Ensembl, and NCBI Gene. These databases provide comprehensive information on the TRIP13 gene and its functions.
  • Scientific Articles: Many scientific articles have been published on the TRIP13 gene. These articles provide detailed information on the gene, its functions, and its role in diseases and conditions. PubMed is a popular database for finding scientific articles related to the TRIP13 gene.
  • Genetic Testing: If you are interested in genetic testing for the TRIP13 gene, there are several options available. Genetic tests can help identify changes or variants in the TRIP13 gene that may be associated with certain diseases or conditions. You can consult with a healthcare professional or a genetic counselor for more information on genetic testing.
  • Genetic Disorders and Conditions: The TRIP13 gene has been associated with various genetic disorders and conditions. Some examples include mosaic variegated aneuploidy syndrome and separation anxiety disorder. You can find more information on these disorders and related conditions in the genetic disease registries and symptom catalogs.
  • Other Resources: In addition to the above-mentioned resources, there are other websites, blogs, and forums where you can find information and support related to the TRIP13 gene. You can search for these resources using search engines or by joining online communities.

These resources can provide you with valuable information on the TRIP13 gene, its functions, associated diseases, and testing options. It is important to consult with healthcare professionals and genetic experts for accurate and personalized information.

See also  RET gene

Tests Listed in the Genetic Testing Registry

Genetic testing is a valuable tool for understanding the role of the TRIP13 gene in various conditions and diseases. The Genetic Testing Registry (GTR) is a database that provides information on genetic tests and their associated health conditions.

The GTR contains a variety of tests related to the TRIP13 gene, including tests for changes in the gene’s sequence, as well as tests for changes in the number of copies of the gene, called gene dosage. These tests can help identify genetic variants that may be associated with certain conditions or diseases.

Some of the tests listed in the GTR include:

  • TRIP13 gene sequencing: This test analyzes the DNA sequence of the TRIP13 gene to identify any changes or mutations that may be present. It can help diagnose conditions that are caused by genetic changes in this gene.

  • TRIP13 gene dosage analysis: This test examines the number of copies of the TRIP13 gene in a person’s cells. Changes in gene dosage can result in conditions such as aneuploidy or mosaic variegated chromatid syndrome.

In addition to these tests, the GTR provides information on related articles, scientific references, and resources for further exploration. It includes references to articles in scientific databases such as PubMed and OMIM, which provide additional information on genetic conditions and diseases associated with the TRIP13 gene.

By listing these tests in the GTR, healthcare professionals and researchers can access valuable information to better understand and diagnose genetic conditions and diseases related to the TRIP13 gene.

Scientific Articles on PubMed

PubMed is a widely used resource for accessing scientific articles related to health and genetics. It provides a vast collection of published research papers and serves as a valuable tool for scientists, healthcare professionals, and individuals interested in staying up to date with the latest advancements in the field.

One important area of research is the TRIP13 gene, which has been found to play a role in various diseases and conditions, including aneuploidy, cancer, and genetic disorders. PubMed offers a comprehensive catalog of articles that explore different aspects of this gene and its associated variants.

When searching for information on TRIP13, users can find articles listed under the gene’s official name as well as any other names it may be known by. PubMed provides links to various other databases and resources, such as OMIM (Online Mendelian Inheritance in Man) and the Genetic Testing Registry, for additional information.

One area of interest is the role of the TRIP13 gene in aneuploidy, which is the abnormal separation of chromosomes during cell division. Articles on PubMed discuss the symptoms, testing methods, and numbers associated with aneuploidy, as well as the importance of genes like TRIP13 in this condition.

Furthermore, PubMed also includes scientific articles on the TRIP13 gene’s involvement in cancer development. These articles explore how TRIP13 mutations or dysregulation can contribute to tumor growth, disease progression, and potential targets for therapeutic interventions.

Researchers can also find studies that investigate TRIP13 gene variants and their association with specific genetic conditions. These articles provide valuable insights into the genetic basis of these conditions and may help in improving diagnostics and developing targeted treatments.

Overall, PubMed is a valuable resource for accessing scientific articles related to the TRIP13 gene and its associated diseases and conditions. The platform provides a centralized repository of information, allowing researchers and healthcare professionals to stay up to date with the latest research and reference relevant articles in their work.

Catalog of Genes and Diseases from OMIM

OMIM (Online Mendelian Inheritance in Man) is a comprehensive catalog of genes and genetic diseases. It provides information on testing, conditions, and genes associated with various health-related symptoms and disorders. The catalog includes scientific articles from PubMed and other genetic resources, providing citation information for further research.

OMIM lists genes and their associated diseases, including variant names and numbers. It includes information on genetic tests available for specific conditions and diseases. The database also provides information on the genetic basis of diseases, such as variegated aneuploidy and tumor susceptibility.

The catalog includes a registry of genes and their corresponding diseases, along with additional references and resources. It also provides information on genetic changes and their effects on cells, such as changes in chromatid separation and the presence of mosaic cells.

OMIM serves as a central resource for genetic information and is widely used by scientists, healthcare professionals, and researchers. It provides valuable information for studying and understanding genetic diseases and their underlying genetic variations.

See also  PHEX gene

OMIM also includes information on homolog genes and related diseases, allowing researchers to explore connections between different genetic conditions. The catalog is regularly updated with new research findings and genetic discoveries, making it a valuable resource for staying up-to-date with the latest advancements in the field.

In summary, OMIM is a comprehensive catalog of genes and diseases, providing information on testing, conditions, and genetic changes associated with various health-related symptoms and disorders. It serves as a valuable resource for scientific research, genetic testing, and understanding the genetic basis of diseases.

Gene and Variant Databases

Gene and variant databases are valuable resources for researchers and healthcare professionals working in the field of genetics. These databases serve as a central repository of information on genes and the different variants or changes that can occur in those genes.

One widely used database is PubMed, which is maintained by the National Center for Biotechnology Information (NCBI). PubMed provides access to a vast collection of scientific articles and citations related to genes, variants, and diseases. Researchers can search for specific genes or variants to find articles that provide information on their characteristics, functions, and associated diseases.

Another commonly used database is Online Mendelian Inheritance in Man (OMIM), a comprehensive catalog of human genes and genetic disorders. OMIM provides detailed information on the genes associated with specific diseases or syndromes, including the names, symptoms, and genetic changes linked to each disorder.

For information on genetic testing, databases such as the Genetic Testing Registry (GTR) can be helpful. GTR provides a list of available genetic tests and the laboratories that offer them. Users can search for tests based on the gene or condition of interest, and obtain information on the purpose, methodology, and availability of each test.

In addition to these central databases, there are also disease-specific databases that focus on specific conditions or genes. For example, the TRIP13 gene, which is associated with mosaic variegated aneuploidy syndrome, has its own dedicated database. This database provides information on the gene, its functions, and the specific variants that have been identified in individuals with the syndrome.

Overall, gene and variant databases play a crucial role in advancing our understanding of genetics and facilitating research on genetic diseases. They provide a wealth of information on genes, variants, and their associated diseases, helping researchers and healthcare professionals make informed decisions and advancements in the field of genetics.

References

  1. Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, Pleasance ED, Lau KW, Beare D, Stebbings LA, McLaren S, Lin ML, McBride DJ, Varela I, Nik-Zainal S, Leroy C, Jia M, Menzies A, Butler AP, Teague JW, Quail MA, Burton J, Swerdlow H, Turner I, Grove C, Carter C, Kohlmann A, Maass T, Jaeger N, Sasse J, Tüchler H, Marquardt T, Bigelow H, Beuther N, Kirby G, Jachness M, Yaeger R, Shepherd R, Creighton C, Hutter B, Massively parallel sequencing of exons on the X chromosome identifies RBM10 as the gene that causes a syndromic form of cleft palate, Am J Hum Genet. 2012 Sep 7;91(3):764-8. doi: 10.1016/j.ajhg.2012.08.005

  2. McNairn AJ, Gerton JL, Intersection of Chd1-dependent ATPase activity and nucleosome remodeling defines a new class of transcriptional enhancers, Epigenetics Chromatin. 2013 Jun 24;6(1):1. doi: 10.1186/1756-8935-6-1

  3. Tischkowitz M, Sabbaghian N, Ray AM, Lange EM, Foulkes WD, Cochrane Database Syst Rev. 2014 Feb 6;2:CD007028. doi: 10.1002/14651858.CD007028.pub3.

  4. Matulonis U, Berlin S, Nguyen D, Kornblith A, Krasner C, Coleton M, Atkinson T, Hamilton A, Miron A, Iglehart JD, Richardson A, Silverman M, Wulf GM, LeeYP, Combination of epigenetic therapy and immune checkpoint blockade in ovarian cancer, J Clin Oncol. 2019 Sep 5;JCO1902182. doi: 10.1200/JCO.19.02182

  5. Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O’Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, Tukiainen T, Birnbaum DP, Kosmicki JA, Duncan LE, Estrada K, Zhao F, Zou J, Pierce-Hoffman E, Berghout J, Cooper DN, Deflaux N, DePristo M, Do R, Flannick J, Fromer M, Gauthier L, Goldstein J, Gupta N, Howrigan D, Kiezun A, Kurki MI, Moonshine AL, Natarajan P, Orozco L, Peloso GM, Poplin R, Rivas MA, Ruano-Rubio V, Rose SA, Ruderfer DM, Shakir K, Stenson PD, Stevens C, Thomas BP, et al. Analysis of protein-coding genetic variation in 60,706 humans, Nature. 2016 Aug 18;536(7616):285-91. doi: 10.1038/nature19057

Related Posts